Subtotal gastrectomy for gastric cancer after living donor liver transplantation and coloproctectomy: a case report
Abstract
The only radical method of treatment of end-stage liver diseases is orthotopic liver transplantation. Number of liver transplantations, from living and cadaveric donors, has been increasing much.
One of the most common late complications after solid organ transplantations, related to immunosuppression therapy, is a high risk of various malignant neoplasms. Malignancy after solid organ
transplantation has been increasing last years, and reached 20% in 10 years after liver transplantation. Gastric neoplasms after liver transplantations are rare cases. In this article we describe a case
of gastric cancer after living donor liver transplantation.
Keywords:gastric cancer, subtotal gastrectomy, living donor liver transplantation
Clin. Experiment. Surg. Petrovsky J. 2016. № 4. Р. 56–60.
Received: 30.08.2016. Accepted: 20.09.2016.
References
1. Buell J.F., Gross T.G., Woodle E.S., Malignancy after transplantation. Transplantation. 2005; Vol. 80: 254-64.
2. Nagata Y., Eguchi S., Takatsuki M., et al. Experience of gastric cancer in a patient who had received a living- donor liver transplantation. Gastric Cancer. 2007; Vol. 10: 187-90.
3. Baccarani U., Adani GL, Montanaro D., et al. De novo malignancies after kidney and liver transplantations: experience on 582 consecutive cases. Transplant Proc. 2006; Vol. 38: 1135-7.
4. Oo Y.H., Gunson B.K., Lancashire R.J., et al. Incidence of cancers following orthotopic liver transplantation in a single center: comparison with national cancer incidence rates for England and Wales. Transplantation. 2005; Vol. 80: 759-64.
5. Cagatay A., Saadettin K., Suayib Y., et al. Gastric cancer after cadaveric liver transplantation in a patient with autoimmune hepatitis: A case report and review of the literature. Turk J Gastroenterol. 2011; Vol. 22 (N 1): 73-6.
6. Buell J.F., Husted T., Hanaway M.J., Trofe J., et al. Gastric cancer in transplant recipients: correction of malignacy by aggressive endoscopy. Transplant Proc. 2002; Vol. 34: 1784-5.
7. Haagsma E.B., Hagens V.E., Schaapveld M., et al. Increased cancer risk after liver transplantation: a population-based study. J Hepatol. 2001; Vol. 34: 84-91.
8. Nagata Y., Eguchi S., Takatsuki M., et al. Experience of gastric cancer in a patient who had received a living-donor liver transplantation. Gastric Cancer. 2007; Vol. 10: 187-90.
9. Imao T., Ichimaru N., Takahara S., et al. Risk factors for malignancy in Japanese renal transplant recipients. Cancer. 2007; Vol. 109: 2109-15.
10. SarkioS.,RautelinH.,KyllnenL.,etal.ShouldHelicobacter pylori infection be treated before kidney transplantation? Nephrol Dial Transpl. 2001; Vol. 16: 2053-7.
11. Karran P., Attard N. Thiopurines in current medical practice: molecular mechanisms and contributions to therapyrelated cancer. Nat Rev Cancer. 2008; Vol. 8: 24-36.